Delivery Order SPE2DB22D3016-SPE2DB25FBGJ5
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for 500 capsules of Loperamide 2 MG, valued at $1,604.37. This firm fixed-price delivery order, awarded on August 11, 2025, with an ultimate completion date of August 12, 2025, was competitively awarded with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Loperamide is an over-the-counter anti-diarrheal medication commonly...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 500 capsules of Loperamide 2 mg, valued at $1,074.23, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $1,413.30 to AmerisourceBergen Drug Corp for the supply of Loperamide 2 mg capsules in quantities of 500 units. This firm fixed-price, non-set-aside contract was awarded on August 5, 2025, with an ultimate completion date of August 6, 2025. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement supporting...
- The Defense Logistics Agency awarded a delivery order valued at $1,088.65 to AmerisourceBergen Drug Corp for Loperamide 2 mg capsules in unit-dose packaging of 100 units. This competitively awarded, firm fixed-price contract was executed on July 21, 2025, with an ultimate completion date of July 22, 2025. The contract carries no set-aside designation and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The U.S. Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Loperamide 2 mg capsules in quantities of 100 units. This firm fixed-price delivery order, valued at $1,596.00, is scheduled for completion by August 11, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The award was competitively procured with no set-aside designation and represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $2,803.00 to AmerisourceBergen Drug Corp for the supply of 500 capsules of Loperamide 2 mg, with an ultimate completion date of August 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's facility in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of 500 capsules of Loperamide 2 mg at a ceiling value of $1,234.15. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract is set to be completed by August 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Loperamide 2 mg capsules in unit dose packages of 100 units. This firm fixed-price delivery order, valued at $2,927.06, represents a non-competitive set-aside award and is scheduled for ultimate completion by July 22, 2025. The contract will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency Medical Supply Chain awarded a $14.7K delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of 500 units of Loperamide 2mg tablets, with completion scheduled for September 4, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $5,290.32 for the supply of Loperamide HCL 500mg capsules on August 15, 2025. This firm fixed-price contract, which is not set-aside and competitively awarded, is scheduled for completion by August 18, 2025. The contract is funded through the Defense Logistics Agency's Medical Supply Chain, a defense agency component, with the place of performance at...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBGJ5Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 500 capsules of Loperamide 2 mg, a common over-the-counter antidiarrheal medication. This competitively awarded, firm fixed-price contract has a ceiling value of $2,084.56 and an ultimate completion date of August 28, 2025. The delivery order was issued on August 27, 2025, with performance to occur at the contractor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999.9 million and extends through December 2026. As a prime pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp supplies a comprehensive range of medications and medical commodities to support federal military and veteran healthcare systems. The company's contract portfolio with DLA demonstrates its capability to fulfill diverse pharmaceutical requirements across multiple therapeutic domains, from common medications like loperamide to specialized treatments and vaccines supporting global military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 8/27/25 |